Skip to content

This is Self Growth Zone, a brand new site by Administrator that's just getting started. Things will be up and running here shortly, but you can subscribe in the meantime if you'd like to stay up to date and receive emails when new content is published!

Latest

Study Results Released on COMP360 Psilocybin for PTSD in Phase 2 Trial by Compass Pathways

Study Results Revealed: Compass Pathways' Phase 2 Trial of COMP360 Psilocybin for Post-Traumatic Stress Disorder Shows Positive Outcomes

Single 25 mg dose of COMP360 psilocybin, administered in an open-label Phase 2 study, demonstrated good tolerability, with no severe adverse events reported. Positive effects, including prompt and enduring symptom improvement from baseline, were noticed up to 12 weeks after a single...